View Document Preview and Link Document Date: 2008-10-02 15:29:21 Open Document File Size: 37,01 KB Share Result on Facebook
Event Product Issues / / Facility PHARMACY NEWSCAPSULE Wisconsin Department of Health Services Division / Institute of Safe Medication Practices / / IndustryTerm medication using electricity / treatment for the mental illness / electricity / / MedicalCondition hypertension / schizophrenia / dementia / harmful hallucinations / diabetic neuropathy / involuntary movement / mania / diabetes / Huntington’s disease / onset mental illness / pain / symptomatic and asymptomatic urinary tract infections / each mental illness / mental illness / potential urinary tract infections / chronic neuropathic pain / apparent asymptomatic urinary tract infections / infection / depression / symptomatic urinary tract infection / idiopathic thrombocytopenic purpura / bipolar disorder / / MedicalTreatment antibiotics / / Organization American Physical Therapy Association / Institute of Safe Medication Practices / Wisconsin Department of Health Services Division of Quality Assurance / / Person Doug Englebert / Corner By Doug Englebert / / Position physician / pharmacist / pharmacist / physician / Consultant / delegate the medication administration / surveyor / physician / etc / physical therapist / physical therapist aide / / Product Xenazine Tetrabenazine Medication / Safe Medication / Combination medication / dexamethasone / risperdal / acetic acid / Cymbalta / risperidone / New Medications Brand Name Generic Name Use Cleviprex Clevidipine Injectable medication / repaglinide / sterile water / product / / URL http / SocialTag 
Pharmacy NewsCapsule - September/October, 2008